Amicus Therapeutics
FOLD
#3908
Rank
A$4.59 B
Marketcap
A$14.90
Share price
-0.50%
Change (1 day)
-1.50%
Change (1 year)

Amicus Therapeutics (FOLD) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.96 Billion

According to Amicus Therapeutics 's latest financial reports the company's total liabilities are A$0.96 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.95 B4.8%
2023-12-31A$0.90 B2.64%
2022-12-31A$0.88 B7.13%
2021-12-31A$0.82 B5.64%
2020-12-31A$0.78 B46.2%
2019-12-31A$0.53 B-15.87%
2018-12-31A$0.63 B80.69%
2017-12-31A$0.35 B-62.59%
2016-12-31A$0.93 B22%
2015-12-31A$0.76 B617.32%
2014-12-31A$0.10 B16.95%
2013-12-31A$91.71 M133.23%
2012-12-31A$39.32 M0.3%
2011-12-31A$39.2 M-16.36%
2010-12-31A$46.87 M211.08%
2009-12-31A$15.06 M-81.58%
2008-12-31A$81.82 M12.13%
2007-12-31A$72.97 M-58.06%
2006-12-31A$0.17 B97.38%
2005-12-31A$88.15 M
2003-12-31A$7.77 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Biogen
BIIB
A$16.56 B 1,623.09%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$2.34 B 144.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$1.22 B 27.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.26 B 9,499.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
A$0.12 B-86.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
A$81.05 B 8,333.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark